 |
 |
|
|
|
| Lovastatin |
 |
| Lovastatin |
 |
| Lovastatin |
 |
Generic Name: Lovastatin
English Name: Lovastatin
Chemical name: (2S)-2-Methyl butanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a -hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
Structural Formula:
Molecular Formula: C24H36O5
Molecular Weight: 404.55
Description: A white crystalline powder.
Pharmacology: HMG-CoA reductase inhibitors have the similar annular or open annular structure as HMG-CoA, which is active after hydrolysis in body. Lovastatin is a specific inhibitor of HMG-CoA reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate. The conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway for cholesterol. Lovastatin can increase LDL receptor and elevate its activity when hepatocyte cholesterol concentration is low, and a great deal LDL is taken to reduce the concentration of plasm and LCL-C. Lovastatin can also reduce the synthesis and release of VLDL.
Indications: Lovastatin is used in the treatment of hypercholesterolemia and mixed hyperlipemia.
packing specification: 20Kg / carton barrel.
Storage: In airtight containers ,at a temperature below +30,avoiding light.
Validity: 2 years
|
 |
Generic Name: Lovastatin
English Name: Lovastatin
Chemical name: (2S)-2-Methyl butanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a -hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
Structural Formula:
Molecular Formula: C24H36O5
Molecular Weight: 404.55
Description: A white crystalline powder.
Pharmacology: HMG-CoA reductase inhibitors have the similar annular or open annular structure as HMG-CoA, which is active after hydrolysis in body. Lovastatin is a specific inhibitor of HMG-CoA reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate. The conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway for cholesterol. Lovastatin can increase LDL receptor and elevate its activity when hepatocyte cholesterol concentration is low, and a great deal LDL is taken to reduce the concentration of plasm and LCL-C. Lovastatin can also reduce the synthesis and release of VLDL.
Indications: Lovastatin is used in the treatment of hypercholesterolemia and mixed hyperlipemia.
packing specification: 20Kg / carton barrel.
Storage: In airtight containers ,at a temperature below +30,avoiding light.
Validity: 2 years
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
